Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates April 28, 2026 8:30 AM EDT
Company Participants
William Roberts - Senior Vice President of Corporate Communications & Investor Relations
Neal Walker - Co-Founder, CEO & Chairman
Hugh M. Davis - President, COO & Director
Jesse Hall - Chief Medical Officer
Roland Kolbeck - Chief Scientific Officer
Conference Call Participants
Thomas Smith - Leerink Partners LLC, Research Division
Biren Amin - Piper Sandler & Co., Research Division
Jeffrey Jones - Oppenheimer & Co. Inc., Research Division
Jiale Song - Jefferies LLC, Research Division
Adam Vogel - Craig-Hallum Capital Group LLC, Research Division
Michael King - Rodman & Renshaw Research
Seamus Fernandez - Guggenheim Securities, LLC, Research Division
Yu Fan - Wedbush Securities Inc., Research Division
Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division
Alexander Thompson - Stifel, Nicolaus & Company, Incorporated, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Aclaris Clinical Program Update Call. [Operator Instructions] Please be advised that today's conference is being recorded. I'd now like to hand the conference over to Will Roberts, Corporate Communications. Please go ahead.
William Roberts
Senior Vice President of Corporate Communications & Investor Relations
Thank you, Liz. Good morning, everyone, and welcome to the Aclaris Therapeutics conference call to discuss this morning's clinical program update, including the positive full top line results from our ATI-052 Phase Ia single and multiple ascending dose clinical trial and our plans to move ATI-2138 into a Phase IIb program in Lichen Planus. The press release on the clinical update was issued earlier this morning and can be found in the Press Releases subpage of the Investor Relations section of our corporate website at aclaristx.com.
Please note that we provided slides as part of this discussion -- they're now available in the webcast window and as
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。